Author Correction: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates
Year: 2018
Type: erratum
Source: Nature Biomedical Engineering
Authors: Marnix Lameijer, Tina Binderup, Mandy M. T. van Leent, Max L. Senders, Francois Fay, Joost Malkus, Brenda L. Sanchez-Gaytan, Abraham J. P. Teunissen, Nicolas Karakatsanis, Philip Robson, Xianxiao Zhou, Yuxiang Ye, Gregory Wojtkiewicz, Jun Tang, Tom T. P. Seijkens, Jeffrey Kroon, Erik S. G. Stroes, Andreas Kjaer, Jordi Ochando, Thomas Reiner, Carlos Pérez-Medina, Claudia Calcagno, Edward A. Fisher, Bin Zhang, Ryan E. Temel, Filip K. Swirski, Matthias Nahrendorf, Zahi A. Fayad, Esther Lutgens, Willem J. M. Mulder, Raphaël Duivenvoorden
Institutions: Amsterdam UMC Location University of Amsterdam, Icahn School of Medicine at Mount Sinai, University of Copenhagen, Rigshospitalet, Harvard University, Massachusetts General Hospital, Center for Systems Biology, Memorial Sloan Kettering Cancer Center, Amsterdam Cardiovascular Sciences, NYU Langone Health, New York University, University of Kentucky, Ludwig-Maximilians-Universität München
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2883626939